Unique ID issued by UMIN | UMIN000037377 |
---|---|
Receipt number | R000042562 |
Scientific Title | Impacts of amino acid mixture on cerebral hemodynamic, metabolic, and cognitive profiles during exercise |
Date of disclosure of the study information | 2019/07/14 |
Last modified on | 2021/03/09 16:12:17 |
The role of nutrition timing system in the interactive effects of interval training and amino acids supplementation on metabolic fitness, cerebral hemodynamics, and cognitive functions (Part 2)
Impacts of amino acid mixture on cerebral hemodynamic, metabolic, and cognitive profiles during exercise
Impacts of amino acid mixture on cerebral hemodynamic, metabolic, and cognitive profiles during exercise
Impacts of AA mixture on CBF, metabolic, and cognitive profiles during exercise
Asia(except Japan) |
The healthy adults who routinely take exercise.
Adult |
Others
NO
Examine the effects of amino acid mixture on the changes in cerebral blood flow regulation and cognitive functions during exercise.
Efficacy
Exploratory
Pragmatic
Not applicable
Cerebral blood flow/hemodynamic profiles, cognitive task performance,glycemic metabolites analysis, cognitive/exercise related biochemical examination of blood/urine.
1. Fatigue related scales (VAS, modified Borg scale)
2. Heart rate response
3. Energy expenditure during exercise
4. Cognitive and exercise related biochemical examinations of blood/urine.
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Treatment
Other |
Consumption of 10 g placebo before performing acute bout of interval exercise (40 min of 75%/60% maximal effort)
Consumption of 10 g amino acid mixture before performing acute bout of interval exercise (40 min of 75%/60% maximal effort)
20 | years-old | <= |
40 | years-old | >= |
Male and Female
1. Subjects who are judged as healthy by self-reported health questionnaire.
2. Subjects who routinely take exercise.
3. Subjects who have no clinical skeletomuscular problems within 12-weeks prior to the study.
4. Subjects who agree to participate in this study with a written informed consent after receiving sufficient explanation relating to this study.
1. Subjects with respiratory, gastrointestinal, hepatic/gallbladder/pancreatic, cardiovascular and/or mental disease, or who have history of those diseases.
2. Subjects who can't take exercise tolerance by bicycle ergometer.
3. Subjects who have a serious injury or surgical history within 12 weeks prior to this study.
4. Subjects who regularly take drugs, foods for specified health uses, foods with function claims and/or supplements, etc. which would affect this study.
5. Subjects who have cognitive disorder or who have possibility of the disorder.
6. Subjects who are judged as unsuitable for this study by the principal investigator or subinvestigators.
20
1st name | Yi-Hung |
Middle name | |
Last name | Liao |
National Taipei University of Nursing and Health Sciences
Department of Exercise and Health Science
11219
Taipei City
+886228227101
yihungliao.henry@gmail.com
1st name | Yi-Hung |
Middle name | |
Last name | Liao |
National Taipei University of Nursing and Health Sciences
Department of Exercise and Health Science
11219
No.365, Ming-Te Road, Peitou District,
+886228227101
yihungliao.henry@gmail.com
National Taipei University of Nursing and Health Sciences
Ministry of Science and Technology
Government offices of other countries
Research Ethics Committee
10087 No.18, Si-yuan Street, Zhong-zheng District, Taipei , Taiwan (R.O.C.) 2-3F of Si-yuan Hall
886233669956
nturec@ntu.edu.tw
NO
National Taipei University of Nursing and Health Sciences (Taipei)
2019 | Year | 07 | Month | 14 | Day |
Unpublished
13
The study was proposed to enroll 20 participants, and 13 participants (13 males; age: 20-38 years) have signed written informed consent forms, and the last participant completed the informed consent forms of this the study by 2019/08/22. The main objective of the study was to investigate the effects of intermittent exercise with amino acid supplementation on cerebral blood flow and cognitive function. All study participants had no adverse reactions during all trials.
All participants had no reports of adverse responses during all trials.
Completed
2019 | Year | 07 | Month | 12 | Day |
2019 | Year | 07 | Month | 12 | Day |
2019 | Year | 07 | Month | 13 | Day |
2020 | Year | 09 | Month | 07 | Day |
2019 | Year | 07 | Month | 14 | Day |
2021 | Year | 03 | Month | 09 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042562
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |